Pharma Journalist -

Clovis Oncology has entered into a global licensing and collaboration agreement with 3B Pharmaceuticals GmbH (3BP), a private German biotechnology company developing targeted…
Read More...

Proteon Therapeutics and ArTara Therapeutics announced that they have entered into a definitive agreement in which a wholly-owned subsidiary of Proteon will merge with ArTara in an…
Read More...

AstraZeneca announced that Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets have been recommended for marketing authorisation in the European…
Read More...

SMi Reports: Renowned microbiologists and industry experts to meet on the Pharmaceutical Microbiology conference taking place in London in January 2020. SMi Group presents the 9th…
Read More...

SMi Reports: Invitation letter released from the chairs of the Pre-Filled Syringes and Injectable Drugs conference taking place in January 2020. SMi Group is delighted to present…
Read More...

Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet…
Read More...

Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.…
Read More...

Cryoport, Inc. announced the launch of its Advanced Therapy Shipper product line for the regenerative medicine market. The Advanced Therapy Shipper guarantees each shipper has been used…
Read More...

Boehringer Ingelheim and Inflammasome Therapeutics announced they have entered into a co-development and license agreement to develop up to three therapies for patients with retinal…
Read More...

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S jointly announced today that the MHLW of Japan approved Trintellix (vortioxetine) for the treatment of depression and depressed…
Read More...